A carregar...
Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer
Insertion mutations in exon 20 (Ex20ins) of the epidermal growth factor receptor (EGFR) gene are the largest class of EGFR mutations in non-small cell lung cancer (NSCLC) for which there are currently no approved targeted therapies. NSCLC patients with these mutations do not respond to clinically ap...
Na minha lista:
| Publicado no: | Pharmgenomics Pers Med |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7955704/ https://ncbi.nlm.nih.gov/pubmed/33727854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S242045 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|